Grant

Polypeptides having glucoamylase activity and polynucleotides encoding them

Patent Number ES-2534067-T3

Publication Year 2015

Granted Year: 2015

Application Year 2010

Priority Year 2009

Jurisdiction ES

Status Active

Inventors

LANDVIK SARA MORANT MARC DOMINIQUE AYABE KEIICHI COWARD-KELLY GUILLERMO

Applicants

Novozymes (Denmark)

[NORA names: Novonesis; Private Research; Denmark; Europe, EU; Nordic; OECD]

Novozymes (United States)

[NORA names: United States; America, North; OECD]

Abstract

1. Isolated polypeptide having glucoamylase activity, selected from the group consisting of: (a) a polypeptide that includes an amino acid sequence having at least 85%, more preferably at least 86%, more preferably at least 87%, more preferably at least 88%, more preferably at least 89%, more preferably at least 90%, more preferably at least 91%, more preferably at least 92%, even of more preferably at least 93%, most preferably at least 94%, and even more preferably at least 95%, such as at least 95%, at least 97%, at least 98%, at least 99 % or even 100% identity with amino acids 18 to 573 of SEQ ID NO: 2, SEQ ID NO: 4, SEQ ID NO: 6, SEQ ID NO: 8, SEQ ID NO: 10, SEQ ID NO: 12, SEQ ID NO: 14 or amino acids 18 to 576 of SEQ ID NO: 16 or SEQ ID NO: 18; (b) a polypeptide that includes an amino acid sequence having at least 86%, more preferably at least 87%, more preferably at least 88%, more preferably at least 89%, more preferably at at least 90%, more preferably at least 91%, more preferably at least 92%, even more preferably at least 93%, most preferably at least 94%, and even more preferably at at least 95%, such as at least 96%, at least 97%, at least 98%, at least 99% or even 100% identity with the catalytic domain shown as amino acids 19 to 474 of SEQ ID NO: 2, SEC ID No: 4, SEQ ID No: 6, SEQ ID No: 8, SEQ ID No: 10, SEQ ID No: 12, SEQ ID No: 14, or amino acids 19 to 471 of SEQ ID No: 16 or SEQ ID No. : 18; (c) a polypeptide encoded by a polynucleotide comprising a nucleotide sequence having at least 85%, more preferably at least 86%, more preferably at least 87%, more preferably at least 88%, of more preferably at least 89%, more preferably at least 90%, more preferably at least 91%, more preferably at least 92%, even more preferably at least 93%, most preferably at least 94%, and even more preferably at least 95%, such as at least 96%, at least 97%, at least 98%, at least 99% or even 100% identity with the SEC coding sequence ID No. 1, SEC ID No. 3, SEC ID No. 5, SEC ID No. 7, SEC ID No. 9, SEC ID No. 11, SEQ ID No. 13, SEQ ID No. 15 or SEQ ID No. : 17 encoding amino acids 18 to 573 of SEQ ID NO: 2, SEQ ID NO: 4, SEQ ID NO: 6, SEQ ID NO: 8, SEQ ID NO: 10, SEQ ID NO: 12, SEQ ID NO: 14, or amino acids 18 to 576 of SEQ ID NO: 16 or SEQ ID nº: 18.

Patent Family Records (21)

Polypeptides having glucoamylase activity and polynucleotides encoding same

Novozymes (Denmark), Novozymes (United States), Novozymes AS, Novozymes North America Inc LANDVIK SARA, M.D. Morant, Habube Kei, (...more)

2024, CN-111593035-B